Drawing for CHATECG

USPTO serial 98218808

CHATECG

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
FARRAG, SHERIF G
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with CHATECG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacey J. Watson

Stacey J. Watson MARKERY LAW LLCP.O. BOX 84150GAITHERSBURG, MD 20883-4150United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for analyzing cardiac data using artificial intelligence; downloadable software for analyzing electrocardiogram (ECG) data and diagnosing cardiac conditions using artificial intelligence; downloadable computer programs featuring artificial intelligence-based algorithms for analyzing electrocardiogram (ECG) signal data; downloadable and recorded computer software using artificial intelligence for machine learning to support clinical data platforms for diagnostics in the fields of cardiology and electrophysiology; downloadable medical software for managing and assessing cardiac data using artificial intelligence; downloadable medical software for electrocardiogram recording, monitoring, analysis, and management using artificial intelligence; computer hardware, recorded software, and peripheral devices for use with mobile computer systems and smartphones, all for medical and veterinary use in monitoring patient physiological indicators and in transmitting physiological health data to patient's healthcare providers; downloadable and recorded computer software for use with mobile computer systems, smartphones, and peripheral devices, all for medical use in monitoring, recording, and analyzing personal physiological activity, analyzing electrocardiogram (ECG) readings, and in transmitting physiological health data; downloadable software for use with mobile computer systems, smartphones and peripheral devices, all for medical use in monitoring, recording, and analyzing personal physiological activity, analyzing electrocardiogram (ECG) readings, transmitting physiological health data and providing additional clinical information, including co-morbidities, medications, procedures, for patients with similar electrocardiogram (ECG) readings; downloadable computer programs and downloadable computer software for the artificial production of human speech and text; downloadable computer programs and downloadable computer software for natural language processing, generation, understanding and analysis; downloadable computer programs and downloadable computer software for machine-learning based language and speech processing software; downloadable computer chatbot software for simulating conversations; downloadable computer programs and downloadable computer software for creating and generating textACTIVE—
038Electronic transmission of data in relation to the use of artificial intelligence and computer science for the prevention, diagnosis and analysis of heart disease, stroke and cardiac arrhythmia and the effect of inherited cardiac disorders as a common cause for electrical disturbances in the heart; providing chat room services for clinicians to discuss medical histories of patientsACTIVE—
042Providing an on-line non downloadable system using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; technical analysis of medical, biological and physiological data generated using medical and electrocardiogram machinery, artificial intelligence, and computer science for the prevention, diagnosis and analysis of heart disease; software as a service (SAAS) services featuring software utilizing algorithms and artificial intelligence for use in machine learning in the field of collecting, analyzing, storing, and transmitting heart sound and electrocardiogram (EKG) recordings of the human body for detection, diagnosis, prediction and prognosis of cardiovascular disease; software as a service (SAAS) services featuring software for analyzing and presenting electrocardiogram and echocardiogram data by applying artificial intelligence-based algorithms to the data; software as a service (SAAS) services featuring software for using artificial intelligence for cardiac disease management; software as a service (SAAS) services featuring software for heart rhythm recording, monitoring, and analysis using artificial intelligence; software as a service (SAAS) services featuring software for analyzing cardiac data using artificial intelligence; software as a service (SAAS) services featuring software for analyzing electrocardiogram (ECG) data and diagnosing cardiac conditions using artificial intelligence; providing online non-downloadable software featuring artificial intelligence-based algorithms for analyzing electrocardiogram (ECG) signal data; providing temporary use of on-line non-downloadable cloud computing software for analysis, interpretation and automatic diagnosis of electrocardiogram exams using artificial intelligence; advanced product research in the field of artificial intelligence; application service provider services, namely, developing, hosting, managing, and maintaining applications, software, web services, and websites, all for medical and veterinary use in monitoring patient physiological indicators and in transmitting and storing physiological health data; software as a service (SaaS) services, namely, hosting software for use by others for developing, hosting, managing, and maintaining applications, software, web services, and websites, all for medical use in monitoring and analyzing patient physiological activity and in transmitting and storing physiological health data none of the foregoing specifically directed to cardiology, critical care, or the physical treatment of structural heart disease; software as a Service (SaaS) services, namely, hosting software for use by others for developing, hosting, managing, and maintaining applications, software, web services, and websites, all for medical use in monitoring, recording, and analyzing personal physiological activity, analyzing electrocardiogram (ECG) readings, and in transmitting physiological health data; providing online non-downloadable software for medical use in monitoring, recording, and analyzing personal physiological activity, analyzing electrocardiogram (ECG) readings, and in transmitting physiological health data; providing online non-downloadable software for the artificial production of human speech and text; providing online non-downloadable software for natural language processing, generation, understanding and analysis; providing online non-downloadable software for machine-learning based language and speech processing software; providing online non-downloadable chatbot software for simulating conversations; providing online non-downloadable software for creating and generating text; research and development services in the field of artificial intelligence; research, design and development of computer programs and softwareACTIVE—
044Providing health information in the nature of electrocardiogram (EKG) and heart rate readings and biometric data; providing health information in the nature of electrocardiogram (EKG) and heart rate readings and biometric data by means of online software applicationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 30, 2026EX3GSOU EXTENSION 3 GRANTED—
Sep 30, 2026EXT3SOU EXTENSION 3 FILED—
Sep 30, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 31, 2026EX2GSOU EXTENSION 2 GRANTED—
Mar 31, 2026EXT2SOU EXTENSION 2 FILED—
Mar 31, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 8, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 30, 2025EX1GSOU EXTENSION 1 GRANTED—
Sep 30, 2025EXT1SOU EXTENSION 1 FILED—
Sep 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 1, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 29, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 29, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 2, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 2, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jun 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2024DOCKASSIGNED TO EXAMINER—
Oct 16, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 14, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance